STAT+: Does Medicare’s ACCESS model pay enough?
Stat News • 2/17/2026
Summary
The news story discusses payment rates for Medicare's ACCESS model and the use of AI by health insurers. It is featured in the edition of STAT Health Tech.
Advertisement
Lindy Score Breakdown (V4.2)
46d
Age
1
Sources
from cluster
1104
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1104/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1104/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 46 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 2 days ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 1 day ago
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 1 day ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • 1 day ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 2 days ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • Today
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago